Bioanalytical Testing Services Market
Bioanalytical Testing Services Market Forecasts to 2030 - Global Analysis By Type (Cell-Based Assays, Virology Testing, Method Development Optimization, Serology, Immunogenicity, Biomarker Testing, Pharmacokinetics Testing, Bioavailability Testing, Bioequivalence Testing, Pharmacodynamics Testing and Other Types), Molecule (Small Molecule and Large Molecule), Workflow, Therapeutic, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $5207.3 MN |
|
Projected Year Value (2030) |
US $116.38 MN |
|
CAGR (2023 - 2030) |
12.2% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Bioanalytical Testing Services Market is accounted for $5207.3 million in 2023 and is expected to reach $116.38 million by 2030 growing at a CAGR of 12.2% during the forecast period. Bioanalytical testing is the term for the analytical process used to examine biological and biotechnological products. In the production of biotechnology and pharmaceuticals, analytical procedures are essential. Drug discovery, development, and commercialization all involve the use of bio analytical evaluation. The bio analytical testing services sector is a subset of the larger life sciences and healthcare sectors that focuses on the examination and testing of biological samples, such as tissues, blood, urine, and other bodily fluids, in order to gather important data for regulatory compliance, clinical diagnosis, and research. It is crucial to many industries, including biotechnology, medicines, environmental monitoring, food safety, and clinical research.
According to a report from the Indian Pharmaceutical Alliance (IPA), the Indian pharmaceutical industry was growing at a rate of 7–8% and is estimated to register USD 80–90 billion in annual revenue by 2030.
Market Dynamics:
Driver:
Rising adoption of the quality by design approach
Pharmaceutical companies are increasingly using the Quality-by-Design (QbD) concept, which has been widely embraced by regulatory bodies like the EMA and US FDA, to improve the quality of their products, the robustness of their manufacturing processes, and the productivity of their factories. With the release of ICH Q8 (R2) (pharmaceutical development), ICH Q9 (quality risk management), and ICH Q10 (pharmaceutical quality system), the QbD method in the pharmaceutical business has evolved throughout time. In the upcoming years, it is anticipated that the growing acceptance and use of the QbD approach among pharmaceutical and biopharmaceutical operations around the world will significantly contribute to the expansion of the global market.
Restraint:
High operational costs
The market for bio analytical testing services is significantly constrained by high operational costs. These costs are required in order to hire highly skilled employees, maintain cutting-edge analytical equipment, and implement strict quality control procedures. The pricey equipment needed for bio analysis is frequently expensive to buy and keep up. Furthermore, high labour expenses are a result of the demand for specialised talent in sectors like chemistry, biology, and data processing. Smaller companies in particular may find it challenging to scale their businesses and make a profit from offering bio analytical testing services, and they may need to make continual investments to stay competitive and comply with industry standards and laws.
Opportunity:
Emergence of advanced and versatile platforms
The emergence of sophisticated and flexible platforms that improve innovative methods has had an impact on the growth of bio analytical testing services. The discipline of bio analysis has advanced recently since new approaches in the sector are capable of handling any issues that can arise. These elements are anticipated to boost the industry's overall growth for bio analytical testing services. Prominent markets are implementing cutting-edge technologies, like dry blood spot technology, to measure pharmacokinetics because it has more benefits than other traditional methods. The dry blood spot method has a number of important advantages, including the need for a small processing sample, easy sample storage, reduced biohazard concerns, the lack of post-collection processing, and many more. Therefore, the presence of advanced technologies is simplifying the quantification process and thereby expected to increase the bio analytical testing services market growth during the forecast period.
Threat:
Client dependence
The market for bio analytical testing services faces a serious challenge from client dependence. Services companies may be financially vulnerable if they rely excessively on a select group of important customers. However, a significant revenue shortfall could come from a key client shifting to another provider or reducing their testing requirements. It is crucial to reducing this danger to diversify the client base and retain solid client relationships through outstanding customer service and value-added services. By diversifying their clientele, businesses can reduce their exposure to the potential loss of a single customer and assure steadier, sustainable growth in the competitive bio analytical testing market.
Covid-19 Impact
The spread of COVID-19 has reduced the output of the industrial sectors, and as a result of its significant impact on several worldwide operations, there has been a rise in demand for effective vaccines, treatments, and other medical services. As a result, the market for bio analytical testing services saw an increase in demand during the epidemic. Healthcare providers relied on point of care services and screening techniques for early viral diagnosis in people. Additionally, the businesses have introduced cutting-edge methodologies and technology that have reduced processing time. The essential techniques include automated sample preparation, ultra-performance liquid chromatography, mass spectrometry, and others. Such advanced technologies as robotics and barcode systems have proved efficient during the pandemic.
The sample preparation segment is expected to be the largest during the forecast period
The sample preparation segment is estimated to hold the largest share. An essential step in the analysis process is sample preparation, which is an emerging area in the bio analytical testing services market. Before being tested or analysed, biological samples must be carefully and methodically prepared. Moreover, techniques for sample preparation include sample extraction, purification, concentration, and occasionally alteration. This component is essential for improving the sensitivity, specificity, and accuracy of analytical techniques and allowing the detection and quantification of small amounts of target compounds.
The virology testing segment is expected to have the highest CAGR during the forecast period
The virology testing segment is anticipated to have lucrative growth during the forecast period. The analysis and detection of viruses in biological samples is the primary focus of the virology testing component of the market. It is essential to clinical research, pharmaceutical development, and public health. The need for virology testing services has grown due to the persistent hazards posed by new viral illnesses and pandemics. This section is crucial for the management and prevention of infectious diseases because it uses a variety of techniques to diagnose and examine viral infections, including PCR, serology, and next-generation sequencing.
Region with largest share:
North America commanded the largest market share during the extrapolated period due to the facilities available across the region and increasing investment for the R&D from US pharmaceutical titans. Additionally, pharmaceuticals are working very hard to create new medicines and they have developed over 1100 oncology treatments that are in various phases of clinical development. The business for bio analytical testing services is expanding across North America because of the presence of major market players like Pfizer.
Region with highest CAGR:
Asia Pacific is expected to witness profitable growth over the projection period. A rise in investments made by organisations offering bio analytical testing services in the region, an increase in the number of companies adopting these services, and corporate and regulatory reforms are other factors driving the market in Asia Pacific. Small enterprises in China and India that are focused on building biologics pipelines, as well as an increase in the pace of adoption of cutting-edge technologies, like single-use technologies, by businesses that provide bio analytical testing services, have boosted the market.
Key players in the market
Some of the key players in the Bioanalytical Testing Services Market include Syneos Health, Intertek Group, Med pace, PPD, Inc., Euro fins Scientific, Laboratory Corporation of America, Pace Analytical Services, ICON plc, PRA Health Sciences , Charles River Laboratories International, Inc., WuXi App Tec, SGS SA Toxikon, Inc., IQVIA, Pharmaceutical Product Development, Frontage Labs, Covance Inc., Alta sciences, BioAgilytix Labs, Vipragen Biosciences and Bio needs India Private Limited.
Key Developments:
In June 2023, ICON plc, one of the world leaders in CRO and healthcare intelligence, announced the release of its new ICON Digital Platform. The platform facilitates seamless integration of ICON site, patient, site, and sponsor services along with harmonized and customizable data delivery.
In June 2023, Syneos Health, one of the leading companies in biopharmaceutical solutions, announced a patient-centric partnership with uMotif, a clinical trial solutions organization. The collaboration is aimed at aiding the acceleration of clinical trials and introducing new therapies to patients via an end-to-end and more effective digital platform. This platform comprises robust Electronic Patient-reported Outcomes (ePRO) and Electronic Clinical Outcome Assessment (eCOA) capabilities
In May 2023, IQVIA a significant provider of advanced analytics, clinical research services, and technology solutions in the world, announced a strategic partnership RED, to battle against AIDS and the injustices that permit pandemics to thrive. This partnership supports laboratory system strengthening.
Types Covered:
• Cell-Based Assays
• Virology Testing
• Method Development Optimization
• Serology, Immunogenicity
• Biomarker Testing
• Pharmacokinetics Testing
• Bioavailability Testing
• Bioequivalence Testing
• Pharmacodynamics Testing
• Other Types
Molecules Covered:
• Small Molecule
• Large Molecule
• Other Molecules
Workflows Covered:
• Sample Preparation
• Sample Analysis
• Other Workflows
Therapeutics Covered:
• Hematology
• Neurology
• Metabolic Disorders
• Oncology
• Immunology
• Orthopedics
• Other Therapeutics
End Users Covered:
• Pharma & Biotechnology Companies
• Contract Research Organizations
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Bioanalytical Testing Services Market, By Type
5.1 Introduction
5.2 Cell-Based Assays
5.2.1 Bacterial Cell-Based Assays
5.2.2 Viral Cell-Based Assays
5.3 Virology Testing
5.3.1 In Vitro Virology Testing
5.3.2 In Vivo Virology Testing
5.3.3 Species-Specific Viral Assays
5.4 Method Development Optimization
5.5 Serology, Immunogenicity
5.6 Biomarker Testing
5.7 Pharmacokinetics Testing
5.8 Bioavailability Testing
5.9 Bioequivalence Testing
5.10 Pharmacodynamics Testing
5.11 Other Types
6 Global Bioanalytical Testing Services Market, By Molecule
6.1 Introduction
6.2 Small Molecule
6.3 Large Molecule
6.3.1 LC-MS Studies
6.3.2 Immunoassays
6.3.2.1 Pharmacokinetics
6.3.2.2 Anti-Drug Antibody
6.4 Other Molecules
7 Global Bioanalytical Testing Services Market, By Workflow
7.1 Introduction
7.2 Sample Preparation
7.2.1 Liquid-Liquid Extraction
7.2.2 Protein Precipitation
7.2.3 Solid Phase Extraction
7.3 Sample Analysis
7.3.1 Chromatographic Technique
7.3.2 Hyphenated Technique
7.3.3 Ligand Binding Assay
7.3.4 Electrophoresis
7.3.5 Nuclear Magnetic Resonance
7.3.6 Mass Spectrometry
7.4 Other Workflows
8 Global Bioanalytical Testing Services Market, By Therapeutic
8.1 Introduction
8.2 Hematology
8.3 Neurology
8.4 Metabolic Disorders
8.5 Oncology
8.6 Immunology
8.7 Orthopedics
8.8 Other Therapeutics
9 Global Bioanalytical Testing Services Market, By End User
9.1 Introduction
9.2 Pharma & Biotechnology Companies
9.3 Contract Research Organizations
9.4 Other End Users
10 Global Bioanalytical Testing Services Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Syneos Health
12.2 Intertek Group
12.3 Medpace
12.4 PPD, Inc.
12.5 Eurofins Scientific
12.6 Laboratory Corporation of America
12.7 Pace Analytical Services
12.8 ICON plc
12.9 PRA Health Sciences
12.10 Charles River Laboratories International, Inc.
12.11 WuXi AppTec
12.12 SGS SA Toxikon, Inc.
12.13 IQVIA
12.14 Pharmaceutical Product Development
12.15 Frontage Labs
12.16 Covance Inc.
12.17 Altasciences
12.18 BioAgilytix Labs
12.19 Vipragen Biosciences
12.20 Bioneeds India Private Limited
List of Tables
1 Global Bioanalytical Testing Services Market Outlook, By Region (2021-2030) ($MN)
2 Global Bioanalytical Testing Services Market Outlook, By Type (2021-2030) ($MN)
3 Global Bioanalytical Testing Services Market Outlook, By Cell-Based Assays (2021-2030) ($MN)
4 Global Bioanalytical Testing Services Market Outlook, By Bacterial Cell-Based Assays (2021-2030) ($MN)
5 Global Bioanalytical Testing Services Market Outlook, By Viral Cell-Based Assays (2021-2030) ($MN)
6 Global Bioanalytical Testing Services Market Outlook, By Virology Testing (2021-2030) ($MN)
7 Global Bioanalytical Testing Services Market Outlook, By In Vitro Virology Testing (2021-2030) ($MN)
8 Global Bioanalytical Testing Services Market Outlook, By In Vivo Virology Testing (2021-2030) ($MN)
9 Global Bioanalytical Testing Services Market Outlook, By Species-Specific Viral Assays (2021-2030) ($MN)
10 Global Bioanalytical Testing Services Market Outlook, By Method Development Optimization (2021-2030) ($MN)
11 Global Bioanalytical Testing Services Market Outlook, By Serology, Immunogenicity (2021-2030) ($MN)
12 Global Bioanalytical Testing Services Market Outlook, By Biomarker Testing (2021-2030) ($MN)
13 Global Bioanalytical Testing Services Market Outlook, By Pharmacokinetics Testing (2021-2030) ($MN)
14 Global Bioanalytical Testing Services Market Outlook, By Bioavailability Testing (2021-2030) ($MN)
15 Global Bioanalytical Testing Services Market Outlook, By Bioequivalence Testing (2021-2030) ($MN)
16 Global Bioanalytical Testing Services Market Outlook, By Pharmacodynamics Testing (2021-2030) ($MN)
17 Global Bioanalytical Testing Services Market Outlook, By Other Types (2021-2030) ($MN)
18 Global Bioanalytical Testing Services Market Outlook, By Molecule (2021-2030) ($MN)
19 Global Bioanalytical Testing Services Market Outlook, By Small Molecule (2021-2030) ($MN)
20 Global Bioanalytical Testing Services Market Outlook, By Large Molecule (2021-2030) ($MN)
21 Global Bioanalytical Testing Services Market Outlook, By LC-MS Studies (2021-2030) ($MN)
22 Global Bioanalytical Testing Services Market Outlook, By Immunoassays (2021-2030) ($MN)
23 Global Bioanalytical Testing Services Market Outlook, By Other Molecules (2021-2030) ($MN)
24 Global Bioanalytical Testing Services Market Outlook, By Workflow (2021-2030) ($MN)
25 Global Bioanalytical Testing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
26 Global Bioanalytical Testing Services Market Outlook, By Liquid-Liquid Extraction (2021-2030) ($MN)
27 Global Bioanalytical Testing Services Market Outlook, By Protein Precipitation (2021-2030) ($MN)
28 Global Bioanalytical Testing Services Market Outlook, By Solid Phase Extraction (2021-2030) ($MN)
29 Global Bioanalytical Testing Services Market Outlook, By Sample Analysis (2021-2030) ($MN)
30 Global Bioanalytical Testing Services Market Outlook, By Chromatographic Technique (2021-2030) ($MN)
31 Global Bioanalytical Testing Services Market Outlook, By Hyphenated Technique (2021-2030) ($MN)
32 Global Bioanalytical Testing Services Market Outlook, By Ligand Binding Assay (2021-2030) ($MN)
33 Global Bioanalytical Testing Services Market Outlook, By Electrophoresis (2021-2030) ($MN)
34 Global Bioanalytical Testing Services Market Outlook, By Nuclear Magnetic Resonance (2021-2030) ($MN)
35 Global Bioanalytical Testing Services Market Outlook, By Mass Spectrometry (2021-2030) ($MN)
36 Global Bioanalytical Testing Services Market Outlook, By Other Workflows (2021-2030) ($MN)
37 Global Bioanalytical Testing Services Market Outlook, By Therapeutic (2021-2030) ($MN)
38 Global Bioanalytical Testing Services Market Outlook, By Hematology (2021-2030) ($MN)
39 Global Bioanalytical Testing Services Market Outlook, By Neurology (2021-2030) ($MN)
40 Global Bioanalytical Testing Services Market Outlook, By Metabolic Disorders (2021-2030) ($MN)
41 Global Bioanalytical Testing Services Market Outlook, By Oncology (2021-2030) ($MN)
42 Global Bioanalytical Testing Services Market Outlook, By Immunology (2021-2030) ($MN)
43 Global Bioanalytical Testing Services Market Outlook, By Orthopedics (2021-2030) ($MN)
44 Global Bioanalytical Testing Services Market Outlook, By Other Therapeutics (2021-2030) ($MN)
45 Global Bioanalytical Testing Services Market Outlook, By End User (2021-2030) ($MN)
46 Global Bioanalytical Testing Services Market Outlook, By Pharma & Biotechnology Companies (2021-2030) ($MN)
47 Global Bioanalytical Testing Services Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
48 Global Bioanalytical Testing Services Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
List of Figures
Figure 1 Global Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 2 North America Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 3 US Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 4 Canada Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 5 Mexico Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 6 Europe Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 7 Germany Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 8 UK Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 9 Italy Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 10 France Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 11 Spain Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 12 Rest of Europe Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 13 Asia Pacific Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 14 Japan Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 15 China Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 16 India Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 17 Australia Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 18 New Zealand Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 19 South Korea Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 20 Rest of Asia Pacific Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 21 South America Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 22 Argentina Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 23 Brazil Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 24 Chile Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 25 Rest of South America Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 26 Middle East & Africa Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 27 Saudi Arabia Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 28 UAE Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 29 Qatar Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 30 South Africa Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
Figure 31 Rest of Middle East & Africa Bioanalytical Testing Services Market Outlook (2021-2030) ($MN)
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
